Course Description: Management paradigms for chronic liver diseases are changing rapidly. This program will review the latest clinically relevant data presented at major liver meetings in 2020. This information will provide clinicians with more effective strategies to improve outcomes for their patients with chronic viral hepatitis, NASH, cirrhosis, portal hypertension, liver cancer, and autoimmune and cholestatic liver disease. While it’s going to look a bit different this year, we will still host our annual High-Impact Hepatology symposium on December 5th, 2020. In an effort to maintain physical distancing, this year’s event will be entirely virtual, and will be broadcast via Zoom Webinar!
Co-sponsored by the UNC Eshelman School of Pharmacy